Skip to main navigation Skip to search Skip to main content

18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer

  • Dennie Meijer
  • , Maurits Wondergem
  • , Remco J. J. Knol
  • , Wouter A. M. Broos
  • , Friso M. van der Zant
  • VU University Medical Center
  • Noordwest Ziekenhuisgroep

Research output: Contribution to journalArticleAcademicpeer-review

12 Downloads (Pure)

Abstract

A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent 18F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased 18F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased 18F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.
Original languageEnglish
Pages (from-to)e96-e97
JournalClinical nuclear medicine
Volume45
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • F-DCFPyL PET/CT
  • follicular lymphoma
  • prostate cancer

Fingerprint

Dive into the research topics of '18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer'. Together they form a unique fingerprint.

Cite this